5 Most Valuable Biotech Companies in the World

1. Johnson & Johnson (NYSE: JNJ)

Market Cap: $452.602 billion
Number of Hedge Fund Holders: 81

Johnson & Johnson (NYSE: JNJ) has landed at the top of the list due to its subsidiary Janssen Biotech, Inc. which is a biotech company with a particular focus on the development of monoclonal antibody technology. The leading pharma giant’s biotech subsidiary is working across six therapeutic areas: immunology, neuroscience, cardiovascular and metabolism, oncology, infectious diseases and vaccines, and pulmonary hypertension. Johnson & Johnson (NYSE: JNJ) has also acquired Momenta pharmaceuticals to expand its portfolio of autoimmune disorder treatments. In fact, this acquisition will give Johnson & Johnson’s biotech division access to other Momenta’s products as well. In 2021, the company has also been awarded a deal by the US government to produce 100 million doses of its COVID-19 vaccine. The company has a market cap of $452.6 billion, earning the top spot in Insider Monkey’s list of the 15 most valuable biotech companies in the world.

You can also take a peek at 10 Stocks with Over 10 Years of Dividend Increases and 15 Best Consumer Discretionary Stocks to Buy Now.

Follow Insider Monkey on Twitter